vs
Side-by-side financial comparison of Agilent Technologies (A) and American Tower (AMT). Click either name above to swap in a different company.
American Tower is the larger business by last-quarter revenue ($2.7B vs $1.8B, roughly 1.5× Agilent Technologies). American Tower runs the higher net margin — 110.1% vs 17.0%, a 93.2% gap on every dollar of revenue. American Tower produced more free cash flow last quarter ($941.0M vs $175.0M). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs 3.7%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
American Tower Corporation, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of approximately 219,000 communications sites. For more information about American Tower, please visit the Earnings Materials and Investor Presentations sections of our investor relations website at www.americantower.com.
A vs AMT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $2.7B |
| Net Profit | $305.0M | $3.0B |
| Gross Margin | 52.6% | — |
| Operating Margin | 19.6% | 0.0% |
| Net Margin | 17.0% | 110.1% |
| Revenue YoY | 7.0% | — |
| Net Profit YoY | -4.1% | — |
| EPS (diluted) | $1.07 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | $2.7B | ||
| Q4 25 | $1.9B | $2.7B | ||
| Q3 25 | $1.7B | $2.7B | ||
| Q2 25 | $1.7B | $2.6B | ||
| Q1 25 | $1.7B | $2.6B | ||
| Q4 24 | $1.7B | $2.5B | ||
| Q3 24 | $1.6B | $2.5B | ||
| Q2 24 | $1.6B | $2.5B |
| Q1 26 | $305.0M | $3.0B | ||
| Q4 25 | $434.0M | $836.8M | ||
| Q3 25 | $336.0M | $912.6M | ||
| Q2 25 | $215.0M | $380.5M | ||
| Q1 25 | $318.0M | $498.6M | ||
| Q4 24 | $351.0M | $1.2B | ||
| Q3 24 | $282.0M | $-780.4M | ||
| Q2 24 | $308.0M | $908.4M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
| Q1 26 | 19.6% | 0.0% | ||
| Q4 25 | 23.8% | 42.4% | ||
| Q3 25 | 20.7% | 45.4% | ||
| Q2 25 | 18.0% | 45.6% | ||
| Q1 25 | 22.4% | 48.9% | ||
| Q4 24 | 24.0% | 42.4% | ||
| Q3 24 | 21.1% | 45.2% | ||
| Q2 24 | 23.1% | 45.4% |
| Q1 26 | 17.0% | 110.1% | ||
| Q4 25 | 23.3% | 30.6% | ||
| Q3 25 | 19.3% | 33.6% | ||
| Q2 25 | 12.9% | 14.5% | ||
| Q1 25 | 18.9% | 19.5% | ||
| Q4 24 | 20.6% | 48.3% | ||
| Q3 24 | 17.9% | -30.9% | ||
| Q2 24 | 19.6% | 35.7% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $1.76 | ||
| Q3 25 | $1.18 | $1.82 | ||
| Q2 25 | $0.75 | $0.78 | ||
| Q1 25 | $1.11 | $1.04 | ||
| Q4 24 | $1.23 | $2.63 | ||
| Q3 24 | $0.97 | $-1.69 | ||
| Q2 24 | $1.05 | $1.92 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $1.6B |
| Total DebtLower is stronger | $3.0B | — |
| Stockholders' EquityBook value | $6.9B | $10.2B |
| Total Assets | $12.8B | — |
| Debt / EquityLower = less leverage | 0.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | $1.6B | ||
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $1.5B | $2.0B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.5B | $2.1B | ||
| Q4 24 | $1.3B | $2.0B | ||
| Q3 24 | $1.8B | $2.2B | ||
| Q2 24 | $1.7B | $2.2B |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $33.8B | ||
| Q3 25 | $3.4B | $34.9B | ||
| Q2 25 | $3.3B | $35.2B | ||
| Q1 25 | $3.3B | $34.0B | ||
| Q4 24 | $3.3B | $32.8B | ||
| Q3 24 | $2.1B | $33.4B | ||
| Q2 24 | $2.1B | $35.6B |
| Q1 26 | $6.9B | $10.2B | ||
| Q4 25 | $6.7B | $3.7B | ||
| Q3 25 | $6.4B | $4.0B | ||
| Q2 25 | $6.1B | $3.7B | ||
| Q1 25 | $6.0B | $3.5B | ||
| Q4 24 | $5.9B | $3.4B | ||
| Q3 24 | $5.9B | $3.6B | ||
| Q2 24 | $6.2B | $3.9B |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $63.2B | ||
| Q3 25 | $12.2B | $63.9B | ||
| Q2 25 | $12.2B | $63.8B | ||
| Q1 25 | $11.9B | $62.1B | ||
| Q4 24 | $11.8B | $61.1B | ||
| Q3 24 | $11.0B | $62.8B | ||
| Q2 24 | $10.9B | $65.8B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 9.26× | ||
| Q3 25 | 0.53× | 8.82× | ||
| Q2 25 | 0.55× | 9.48× | ||
| Q1 25 | 0.56× | 9.63× | ||
| Q4 24 | 0.57× | 9.70× | ||
| Q3 24 | 0.36× | 9.16× | ||
| Q2 24 | 0.34× | 9.24× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | — |
| Free Cash FlowOCF − Capex | $175.0M | $941.0M |
| FCF MarginFCF / Revenue | 9.7% | 34.4% |
| Capex IntensityCapex / Revenue | 5.2% | 16.8% |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $6.7B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $5.5B | ||
| Q3 25 | $362.0M | $1.5B | ||
| Q2 25 | $221.0M | $1.3B | ||
| Q1 25 | $431.0M | $1.3B | ||
| Q4 24 | $481.0M | $5.3B | ||
| Q3 24 | $452.0M | $1.5B | ||
| Q2 24 | $333.0M | $1.3B |
| Q1 26 | $175.0M | $941.0M | ||
| Q4 25 | $452.0M | $3.8B | ||
| Q3 25 | $259.0M | $994.5M | ||
| Q2 25 | $107.0M | $976.9M | ||
| Q1 25 | $334.0M | $963.9M | ||
| Q4 24 | $388.0M | $3.7B | ||
| Q3 24 | $360.0M | $1.0B | ||
| Q2 24 | $230.0M | $1.0B |
| Q1 26 | 9.7% | 34.4% | ||
| Q4 25 | 24.3% | 138.2% | ||
| Q3 25 | 14.9% | 36.6% | ||
| Q2 25 | 6.4% | 37.2% | ||
| Q1 25 | 19.9% | 37.6% | ||
| Q4 24 | 22.8% | 145.3% | ||
| Q3 24 | 22.8% | 41.4% | ||
| Q2 24 | 14.6% | 39.8% |
| Q1 26 | 5.2% | 16.8% | ||
| Q4 25 | 5.0% | 61.4% | ||
| Q3 25 | 5.9% | 17.1% | ||
| Q2 25 | 6.8% | 11.6% | ||
| Q1 25 | 5.8% | 12.9% | ||
| Q4 24 | 5.5% | 62.4% | ||
| Q3 24 | 5.8% | 16.8% | ||
| Q2 24 | 6.5% | 12.8% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 6.53× | ||
| Q3 25 | 1.08× | 1.60× | ||
| Q2 25 | 1.03× | 3.37× | ||
| Q1 25 | 1.36× | 2.60× | ||
| Q4 24 | 1.37× | 4.30× | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.08× | 1.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
AMT
Segment breakdown not available.
